Skip to main content
Erschienen in: Clinical Rheumatology 11/2016

27.07.2016 | Brief Report

No impairment of pulmonary function in children with Henoch-Schonlein purpura after 4-year follow-up

verfasst von: Izabela Grabska-Kobylecka, Dariusz Nowak, Anna Wlodarczyk, Piotr Bialasiewicz

Erschienen in: Clinical Rheumatology | Ausgabe 11/2016

Einloggen, um Zugang zu erhalten

Abstract

Henoch-Schonlein purpura (HSP) is a generalized form of IgA-mediated vasculitis that usually spares pulmonary circulation. Nevertheless, it is conceivable that subclinical changes at the HSP onset may lead to lung impairment in the long term. Therefore, we decided to follow a group of HSP patients for 4 years to monitor changes in pulmonary function. A group of 11 children and adolescents diagnosed with HSP without apparent pulmonary involvement was subjected to pulmonary function tests (PFTs), i.e., spirometry, body plethysmography, and diffusing capacity for CO (DLCO); these tests were repeated after 48 months. No significant impairment was observed in variables of spirometry, body plethysmography, and DLCO expressed as % of predicted values (% predicted) after 4 years. Specifically, no significant change in DLCO, corrected for blood hemoglobin concentration was noted, i.e., 79.3 ± 10.1 vs. 81.6 ± 14.7 % predicted at the beginning and the end of the study, respectively. IgA vasculitis seems to spare pulmonary circulation as we found no impairment in PFTs within the study time frame and a median of almost 6 years from the first episode of the disease.
Literatur
2.
Zurück zum Zitat Nadrous HF, Yu AC, Specks U, Ryu JH (2004) Pulmonary involvement in Henoch-Schönlein purpura. Mayo Clin Proc 79:1151–1157PubMed Nadrous HF, Yu AC, Specks U, Ryu JH (2004) Pulmonary involvement in Henoch-Schönlein purpura. Mayo Clin Proc 79:1151–1157PubMed
3.
Zurück zum Zitat Chaussain M, de Boissieu D, Kalifa G et al (1992) Impairment of lung diffusion capacity in Schönlein-Henoch purpura. J Pediatr 121:12–16CrossRefPubMed Chaussain M, de Boissieu D, Kalifa G et al (1992) Impairment of lung diffusion capacity in Schönlein-Henoch purpura. J Pediatr 121:12–16CrossRefPubMed
5.
Zurück zum Zitat Epler G, McLoud T, Gaensler E, Mikus J, Carrington C (1978) Normal chest roentgenograms in chronic diffuse infiltrative lung disease. N Engl J Med 298:934–939CrossRefPubMed Epler G, McLoud T, Gaensler E, Mikus J, Carrington C (1978) Normal chest roentgenograms in chronic diffuse infiltrative lung disease. N Engl J Med 298:934–939CrossRefPubMed
6.
Zurück zum Zitat Ozen S, Pistorio A, Iusan SM et al (2010) EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. Ann Rheum Dis 69:798–806. doi:10.1136/ard.2009.116657 CrossRefPubMed Ozen S, Pistorio A, Iusan SM et al (2010) EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. Ann Rheum Dis 69:798–806. doi:10.​1136/​ard.​2009.​116657 CrossRefPubMed
7.
Zurück zum Zitat Cazzato S, Bernardi F, Cinti C et al (1999) Pulmonary function abnormalities in children with Henoch-Schönlein purpura. Eur Respir J 13:597–601CrossRefPubMed Cazzato S, Bernardi F, Cinti C et al (1999) Pulmonary function abnormalities in children with Henoch-Schönlein purpura. Eur Respir J 13:597–601CrossRefPubMed
Metadaten
Titel
No impairment of pulmonary function in children with Henoch-Schonlein purpura after 4-year follow-up
verfasst von
Izabela Grabska-Kobylecka
Dariusz Nowak
Anna Wlodarczyk
Piotr Bialasiewicz
Publikationsdatum
27.07.2016
Verlag
Springer London
Erschienen in
Clinical Rheumatology / Ausgabe 11/2016
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-016-3358-y

Weitere Artikel der Ausgabe 11/2016

Clinical Rheumatology 11/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Neu im Fachgebiet Innere Medizin

22.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Krebspatienten impfen: Was? Wen? Und wann nicht?

22.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Nierenultraschall: Tipps vom Profi

22.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

„KI sieht, was wir nicht sehen“

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.